Global Youth Coalition on HIV/AIDS - Groups - Action Tools

Message

From:	Lindsay Menard-Freeman [ profile ]
Subject:	NPR Blog: Who should take Truvada?
Sent:	Jul 17th, 2012 - 10:50:43

	[Excerpt July 17, 2012] There's something new to prevent HIV infections. The Food and Drug Administration on Monday approved a once-a-day pill that can drastically lower a person's risk of getting the virus that causes AIDS. It's called Truvada - the first HIV prevention pill. It's not cheap - around $13,000 a year - and it's not clear what insurers will pay for it. And there's worry that people taking the pill might relax safe-sex precautions. But health officials hope the pill will help reduce the number of Americans who get HIV every year - a figure that has hovered around 50,000 for years. While it sounds simple, the new prevention strategy involves a bunch of complicated issues. For the full blog post: http://www.npr.org/blogs/health/2012/07/17/156868446/deciding-on-truvada-who-should-take-new-hiv-prevention-pill --- Lindsay Menard-Freeman, MA Advocacy & Communications Manager Women Deliver 584 Broadway, Suite 306 New York, NY 10012, USA Tel: +1 646.502.9839 Fax: + 1 646.695.9145 E-mail: lmenardfreeman (at) womendeliver.org www.womendeliver.org Read our updates. Follow us on Twitter. Join us on Facebook.

		Groups Powered by TakingITGlobal